MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$5,355K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Accrued expenses and other curre...
Prepaid expenses and other curre...
Non-cash lease cost
Other receivables
Negative Cash Flow Breakdown
Net loss
Operating lease liability
Accounts payable
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-9,552
-7,203
31,520
-7,382
Depreciation and amortization
-
-
0
0
Non-cash lease cost
227
226
214
283
Impairment of assets
-
-
0
587
Share-based compensation
822
1,114
1,007
1,048
Collaboration receivable, current and non-current - related party
0
-25,359
24,491
-23,585
Other receivables
-19
16
-1,563
-869
Prepaid expenses and other current assets
-654
-195
386
-47
Other assets
-
-
0
0
Accounts payable
-62
-476
-702
615
Accrued expenses and other current liabilities
2,968
-2,436
-2,231
1,082
Deferred revenue, current and non-current
0
0
-12,575
0
Deferred revenue - related party, current and non-current
0
-258
-2,125
-3,048
Other long-term liabilities
-
-
91
0
Operating lease liabilities
-
-
-1,402
-
Operating lease liability
-431
525
-
-264
Income taxes payable
0
-220
220
0
Net cash provided by (used in) operating activities
-5,355
15,864
-8,351
17,422
Net increase (decrease) in cash and cash equivalents
-5,355
15,864
-8,351
17,422
Cash, cash equivalents and restricted cash at beginning of period
56,129
40,265
48,616
52,889
Cash, cash equivalents and restricted cash at end of period
50,774
56,129
40,265
48,616
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net increase
(decrease) in cash and cash...
-$5,355K
(75.32%↑ Y/Y)
Accrued expenses and
other current...
$2,968K
(126.99%↑ Y/Y)
Share-based compensation
$822K
(-63.79%↓ Y/Y)
Prepaid expenses and
other current assets
-$654K
(-6.17%↓ Y/Y)
Non-cash lease cost
$227K
(-58.80%↓ Y/Y)
Other receivables
-$19K
(96.96%↑ Y/Y)
Net cash provided by
(used in) operating...
-$5,355K
(75.32%↑ Y/Y)
Canceled cashflow
$4,690K
Net loss
-$9,552K
(38.64%↑ Y/Y)
Operating lease liability
-$431K
(36.80%↑ Y/Y)
Accounts payable
-$62K
(99.05%↑ Y/Y)
Buy us a coffee
Spero Therapeutics, Inc. (SPRO)
Spero Therapeutics, Inc. (SPRO)